Scientist.com

We sat down with Dr. Licy Yanes Cardozo, Professor of Medicine, Endocrinology & Pharmacology at the University of Mississippi Medical Center to discuss her research on the role and mechanisms by which androgen excess mediates cardiovascular disease in women. Watch or listen to the full interview, here: https://lnkd.in/gmdg4d-W You can also join her live tomorrow as she presents "Polycystic Ovarian Syndrome and Cardiovascular Disease", the last installment in our Women's Health Webinar Series before the holidays. Register here: https://lnkd.in/e3PPXFjt Interviewer: Sarah McFarlane

EMPLOYEE SPOTLIGHT 👏 "Thrilled to have been selected for the Voices of Tomorrow program by Global Biotech Revolution, and honored with the Top Innovator award for my team's work on neurodegenerative diseases. Grateful to Scientist.com for fostering an innovative and supportive environment that has accelerated my professional development." Robert Matthews is one of the bioinformaticians at Scientist.com and has helped create and maintain new bioanalysis tools for expedited research including the Tumor Model Finder and our new Omic Analysis Tool, which you can now explore here: https://lnkd.in/gkT98q5w

"Make genome editing easier" is the goal of Ubigene Biosciences. How are their products and services making this a reality? Find out in our latest edition of Supplier Spotlight®: https://lnkd.in/gvPwc9NS

We're looking forward to sponsoring the R&D Procurement & Outsourcing in Biopharma Summit in San Diego next week where our VP of Business Development, Natalie Duner will be presenting "Navigate R&D Procurement with Ease: Introducing Scientist.com’s Co-Pilot". Don't miss this opportunity to connect with fellow industry leaders and enhance your R&D procurement and outsourcing strategy. What are you waiting for? Join us at the summit! Register here: https://lnkd.in/ghgaHxkr

Get to know Indivumed Services, your partner for biomarker discovery and drug and CDx development to realize personalized oncology. In this edition of Supplier Spotlight®, we asked them a few questions about their service offerings, what problems they help solve, new product and service developments & more. Read the full blog post now: https://lnkd.in/gQNxqWU8 Crown Bioscience

Introducing Tissue 2 Target, a one-stop service wherein you can procure high-quality, well-characterized human biospecimens and obtain advanced genomic analysis of the samples seamlessly and effectively. Read the full blog post to learn more about this partnership between Cureline Group - Global Translational CRO and Cellecta, Inc. as well as to access their case study on identifying putative biomarkers for rheumatoid arthritis, here: https://lnkd.in/gRJX42mG

Epigenomics is rapidly gaining recognition as a crucial approach in the field of cancer research. Learn how Hologic Diagenode applied their two decades of epigenomic knowledge to support Universal Diagnostics S.A. in the development of their early-detection workflow for colorectal cancer (CRC) that utilizes liquid biopsies. Read the full blog here: https://lnkd.in/grTfu7VK You may not copy, reproduce, distribute, publish, display, perform, modify, create derivative works from, transmit or exploit in any way any of the content. All content is the property of Universal Diagnostics.

View Dr. Camelia Quek's presentation on the innovative use of longitudinal multimodal single-cell analysis and spatial inference to uncover the complexities of the tumor microenvironment (TME) of advanced melanoma patients with innate resistance, acquired resistance or response to immunotherapy. Attendees will gain a deeper understanding of how these discoveries can inform future therapeutic strategies and improve patient outcomes. Watch it now: https://lnkd.in/grXTMB8P Akoya Biosciences, Inc.

In a recent Nature article, Andrew Bradbury and Andreas Plückthun call for a shift in standard research methods toward the use of properly validated, recombinant protein binding reagents. That's where Miltenyi Biotec comes in. Learn how their REAfinity Antibodies are designed for structural standardization, lot-to-lot homogeneity and high binding specificity. Read the full blog post here: https://lnkd.in/ghhrJyu9

Cell viability is an essential measurement in research areas like drug discovery, toxicology, cancer biology and immunotherapy—understanding this measurement is key to evaluating how cells thrive or die under different conditions. In this blog post, BPS Bioscience Inc. shares what factors to consider when choosing a viability assay and more! Read it here: https://lnkd.in/gq8vCXmW